Continuing Education
A Review of Prostate Cancer & Recent Updates in the Treatment of Metastatic Prostate Cancer On-Demand (NCODA Fall Summit 2024)
Best Suited For: Pharmacist, Pharmacy Technician, Nurse
CE Credits: 1 hours
Related Topics: Prostate Cancer, Oral Oncolytics
Activity Description
Prostate cancer is a hormonally mediated disease that affects a large percentage of men. Providers and patients have many medication treatment options including hormonal manipulations, anti-androgens, CYP17 inhibitors, chemotherapy, immunotherapy, and targeted therapy. This activity will provide learners an overview of the elements of prostate cancer diagnosis and treatment, as well as review the multiple recent medication approvals for the treatment of metastatic disease and their adverse effects.
CE Credit: 1 hour
Fee: This activity does not require payment to register.
Learning Objectives
- Explain the background of prostate cancer
- Outline the elements of a prostate cancer diagnosis
- Discuss the recent updates in metastatic castration-resistant prostate cancer treatment
- Describe the adverse effect profile of the medications recently approved for metastatic castration-resistant prostate cancer
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted will be viewable in your CPE Monitor profile within 24 hours.
